Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Drugs
INR 15 Cr (Micro Cap)
15.00
33
0.00%
-0.24
-4.17%
-10.57
Revenue and Profits (1 Year):
Net Sales:
0 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.20%
EBIT Growth (5y)
3.19%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
1.76%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
33
Price to Book Value
-10.57
EV to EBIT
-15.56
EV to EBITDA
-15.56
EV to Capital Employed
-14.15
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2024
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Venkat Narender Nuka (17.69%)
Highest Public shareholder
Percy Homi Italia (8.9%)
Individual Investors Holdings
65.54%
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ
Dec'24
Sep'24
Change(%)
Net Sales
0.20
0.17
17.65%
Operating Profit (PBDIT) excl Other Income
-0.49
-0.30
-63.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.50
-0.30
-66.67%
Operating Profit Margin (Excl OI)
-245.00%
-176.47%
-68.53%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Dec 2024 is 17.65% vs 0.00% in Sep 2024
Standalone Net Profit
QoQ Growth in quarter ended Dec 2024 is -66.67% vs -700.00% in Sep 2024
Annual Results Snapshot (Standalone) - Mar'24
Mar'24
Change(%)
Net Sales
0.00
NA
NA
Operating Profit (PBDIT) excl Other Income
-0.10
NA
NA
Interest
0.00
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
0.06
NA
NA
Operating Profit Margin (Excl OI)
0.00%
NA%
NA
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
About Venmax Drugs & Pharmaceuticals Ltd 
Venmax Drugs & Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of "Yenkay Medico Private Limited", on 28 September, 1998. The Company thereafter changed its name to "Yenkey Drugs & Pharmaceuticals Private Limited" on 18 January, 1995. It became a Public Limited Company on February 3, 1995 with "Yenkey Drugs & Pharmaceuticals Limited". Finally, the Company changed its name to "Venmax Drugs & Pharmaceuticals Limited" on April 13, 2009.
Company Coordinates 
Company Details
H.No 1-140 Rajeswari Warehouse, Kompally Quthbullapur Hyderabad Telangana : 500014
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad